Proxy Firms Urge Shareholders To Reject Strides Pharma’s Proposed Business Consolidation Over Valuation Concerns
Proxy advisory firms Stakeholders Empowerment Services (SES), Institutional Investors Advisory Services (IiAS), and Institutional Shareholder Services (ISS) have advised investors to vote against the proposed consolidation of certain businesses of Strides Pharma Science with two of its group compani
